Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Burrows

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
The Journal of Experimental Medicine|November 1, 1996
Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosisS L Silins, S M Cross, S L Elliott, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia virusesR J Murray, M G Kurilla, H M Griffin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative diseaseR Khanna, S Bell, M Sherritt, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Quantitative and qualitative influences of tapasin on the class I peptide repertoireA W Purcell, J J Gorman, M Garcia-Peydró, et al.
The Journal of Experimental Medicine|August 1, 1996
Interleukin-1 beta-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killingQ Song, S R Burrows, G Smith, et al.
Immunity|May 24, 2001
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complexX N Xu, M A Purbhoo, N Chen, et al.
Clinical and Experimental Immunology|October 1, 2015
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaK Jones, L Wockner, R M Brennan, et al.
Neurology|July 15, 2011
Current and past Epstein-Barr virus infection in risk of initial CNS demyelinationR M Lucas, A-L Ponsonby, K Dear, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Journal of Experimental Medicine|November 1, 1996
Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosisS L Silins, S M Cross, S L Elliott, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia virusesR J Murray, M G Kurilla, H M Griffin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative diseaseR Khanna, S Bell, M Sherritt, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
Quantitative and qualitative influences of tapasin on the class I peptide repertoireA W Purcell, J J Gorman, M Garcia-Peydró, et al.
The Journal of Experimental Medicine|August 1, 1996
Interleukin-1 beta-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killingQ Song, S R Burrows, G Smith, et al.
Immunity|May 24, 2001
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complexX N Xu, M A Purbhoo, N Chen, et al.
Clinical and Experimental Immunology|October 1, 2015
The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphomaK Jones, L Wockner, R M Brennan, et al.
Neurology|July 15, 2011
Current and past Epstein-Barr virus infection in risk of initial CNS demyelinationR M Lucas, A-L Ponsonby, K Dear, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Pageof 8